Researchers develop an AI-based platform that integrates reaction data with catalyst performance for the design of new ...

CatDRX is a generative AI framework developed at Institute of Science Tokyo, which enables the design of new chemical catalysts based on the specific chemical reactions in which they are used. The ...

Disentangled variational autoencoder (D-VAE) separates materials properties from the latent space by conditioning to make inverse materials design more efficient and transparent. It combines labeled ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research ...

Merck & Co. is taking a look at a generative AI platform. As an early user of Variational AI’s technology, the Big Pharma will assess the ability of the platform to generate novel small molecules that ...

Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...

The research team included, back row, from left, Shih-I (Harry) Tan, Nilmani Singh, Aashutosh Boob, and front row, from left, Teresa Martin, Li-Qing Chen, and Huimin Zhao. The mitochondrion, often ...